[Retracted] Clinical Application Value of High-Frequency Ultrasound Combined with Detection of Serum High Mobility Group Box 1, Soluble IL-2 Receptor, and Thyroglobulin Antibody in Diagnosing Thyroid Cancer

<div>Comparison of blood flow parameters between the thyroid cancer group and the benign lesion group (<i>x</i> ± <i>s</i>). # indicates <i>P</i> &lt; 0.001.</div>

Journal of Healthcare Engineering

fig1

Figure 1

Figure 1: [Retracted] Clinical Application Value of High-Frequency Ultrasound Combined with Detection of Serum High Mobility Group Box 1, Soluble IL-2 Receptor, and Thyroglobulin Antibody in Diagnosing Thyroid Cancer 

Figure 1 | [Retracted] Clinical Application Value of High-Frequency Ultrasound Combined with Detection of Serum High Mobility Group Box 1, Soluble IL-2 Receptor, and Thyroglobulin Antibody in Diagnosing Thyroid Cancer 